Postma MJ - Search Results

1

The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands.

van Hulst M, Stevanovic J, Jacobs MS, Tieleman RG, Kappelhoff B, Postma MJ. van Hulst M, et al. Among authors: postma mj. J Med Econ. 2018 Jan;21(1):38-46. doi: 10.1080/13696998.2017.1372222. Epub 2017 Sep 7. J Med Econ. 2018. PMID: 28836865 Free article.

2

Cost effectiveness of expanded antenatal HIV testing in London.

Postma MJ, Beck EJ, Hankins CA, Mandalia S, Jager JC, de Jong-van den Berg LT, Walters MD, Sherr L. Postma MJ, et al. AIDS. 2000 Oct 20;14(15):2383-9. doi: 10.1097/00002030-200010200-00020. AIDS. 2000. PMID: 11089627

3

Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands.

Postma MJ, Heijnen ML, Jager JC. Postma MJ, et al. Pharmacoeconomics. 2001;19(2):215-22. doi: 10.2165/00019053-200119020-00008. Pharmacoeconomics. 2001. PMID: 11284385

4

Cost-effectiveness of HIV screening of patients attending clinics for sexually transmitted diseases in Amsterdam.

Bos JM, Fennema JS, Postma MJ. Bos JM, et al. Among authors: postma mj. AIDS. 2001 Oct 19;15(15):2031-6. doi: 10.1097/00002030-200110190-00017. AIDS. 2001. PMID: 11600833

5

Pharmaco-economics of blood transfusion safety: review of the available evidence.

van Hulst M, de Wolf JT, Staginnus U, Ruitenberg EJ, Postma MJ. van Hulst M, et al. Among authors: postma mj. Vox Sang. 2002 Aug;83(2):146-55. doi: 10.1046/j.1423-0410.2002.00198.x. Vox Sang. 2002. PMID: 12201844 Review.

6

Cost-effectiveness of leucocyte depletion of red-cell transfusions for patients undergoing cardiac surgery.

Postma MJ, van de Watering LM, de Vries R, Versmoren D, van Hulst M, Tobi H, van der Poel CL, Brand A. Postma MJ, et al. Vox Sang. 2003 Jan;84(1):65-7. doi: 10.1046/j.1423-0410.2003.00245.x. Vox Sang. 2003. PMID: 12542735 No abstract available.

7

Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery.

van Hulst M, Bilgin YM, van de Watering LM, de Vries R, van Oers MH, Brand A, Postma MJ. van Hulst M, et al. Among authors: postma mj. Transfus Med. 2005 Jun;15(3):209-17. doi: 10.1111/j.1365-3148.2005.00573.x. Transfus Med. 2005. PMID: 15943705

8

Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands.

Postma MJ, van Hulst M, De Wolf JT, Botteman M, Staginnus U. Postma MJ, et al. Transfus Med. 2005 Oct;15(5):379-87. doi: 10.1111/j.1365-3148.2005.00609.x. Transfus Med. 2005. PMID: 16202052

9

Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data.

de Vries R, van Bergen JE, de Jong-van den Berg LT, Postma MJ; PILOT-CT Study Group. de Vries R, et al. Among authors: postma mj. Value Health. 2006 Jan-Feb;9(1):1-11. doi: 10.1111/j.1524-4733.2006.00075.x. Value Health. 2006. PMID: 16441519 Free article.

10

Combination vaccine against invasive meningococcal B and pneumococcal infections: potential epidemiological and economic impact in the Netherlands.

Bos JM, Rümke HC, Welte R, Spanjaard L, van Alphen L, Postma MJ. Bos JM, et al. Among authors: postma mj. Pharmacoeconomics. 2006;24(2):141-53. doi: 10.2165/00019053-200624020-00004. Pharmacoeconomics. 2006. PMID: 16460135

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

678 results

Search Page

Filters